CinDome Pharma announces successful completion of thorough QT study of CIN- 102

CinDome Pharma, Inc. a clinical-stage biopharmaceutical company and member of the CinRx Pharma portfolio, today announced the negative results of a clinical thorough QT/QTc study of CIN-102.

INVESTOR INQUIRIES

CAREER INQUIRIES

GENERAL INQUIRIES